Identification of a potent synthetic FXR agonist with an unexpected mode of binding and activation
- 8 April 2008
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 105 (14), 5337-5342
- https://doi.org/10.1073/pnas.0710981105
Abstract
The farnesoid X receptor (FXR), a member of the nuclear hormone receptor family, plays important roles in the regulation of bile acid and cholesterol homeostasis, glucose metabolism, and insulin sensitivity. There is intense interest in understanding the mechanisms of FXR regulation and in developing pharmaceutically suitable synthetic FXR ligands that might be used to treat metabolic syndrome. We report here the identification of a potent FXR agonist (MFA-1) and the elucidation of the structure of this ligand in ternary complex with the human receptor and a coactivator peptide fragment using x-ray crystallography at 1.9-A resolution. The steroid ring system of MFA-1 binds with its D ring-facing helix 12 (AF-2) in a manner reminiscent of hormone binding to classical steroid hormone receptors and the reverse of the pose adopted by naturally occurring bile acids when bound to FXR. This binding mode appears to be driven by the presence of a carboxylate on MFA-1 that is situated to make a salt-bridge interaction with an arginine residue in the FXR-binding pocket that is normally used to neutralize bound bile acids. Receptor activation by MFA-1 differs from that by bile acids in that it relies on direct interactions between the ligand and residues in helices 11 and 12 and only indirectly involves a protonated histidine that is part of the activation trigger. The structure of the FXR:MFA-1 complex differs significantly from that of the complex with a structurally distinct agonist, fexaramine, highlighting the inherent plasticity of the receptor.Keywords
This publication has 44 references indexed in Scilit:
- Partial Agonists Activate PPARγ Using a Helix 12 Independent MechanismStructure, 2007
- Structural Characterization of the Human Androgen Receptor Ligand-binding Domain Complexed with EM5744, a Rationally Designed Steroidal Ligand Bearing a Bulky Chain Directed toward Helix 12Online Journal of Public Health Informatics, 2007
- FXR, a multipurpose nuclear receptorTrends in Biochemical Sciences, 2006
- Farnesoid X receptor is essential for normal glucose homeostasisJCI Insight, 2006
- LIGAND CONTROL OF COREGULATOR RECRUITMENT TO NUCLEAR RECEPTORSAnnual Review of Physiology, 2005
- Structural adaptability in the ligand-binding pocket of the ecdysone hormone receptorNature, 2003
- The Amino Acid Residues Asparagine 354 and Isoleucine 372 of Human Farnesoid X Receptor Confer the Receptor with High Sensitivity to ChenodeoxycholateOnline Journal of Public Health Informatics, 2002
- Use of Homogeneous Time-Resolved Fluorescence Energy Transfer in the Measurement of Nuclear Receptor ActivationMethods, 2001
- Ligand-induced stabilization of PPARγ monitored by NMR spectroscopy: implications for nuclear receptor activationJournal of Molecular Biology, 2000
- The CCP4 suite: programs for protein crystallographyActa crystallographica. Section D, Structural biology, 1994